University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

A

Status	Drug name	NICE TAs	Comments
	Abaloparatide (Eladynos®)	TA991: Abaloparatide for treating osteoporosis after menopause
	Abatacept	TA195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed	Hospital use only
	Abciximab injection	TA47 - Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (partially updated by CG94)	Hospital use only
	Abemaciclib (Verzenios®)	TA563 - Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer TA725 - Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy TA810: Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence
	Abidec drops (25ml)		Contains arachis (peanut) oil.
	Abiraterone tablets	TA259 - Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen TA387 - Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
	Acalabrutinib	TA689 - Acalabrutinib for treating chronic lymphocytic leukaemia
	Acamprosate E/C tablets
	Acenocoumarol tablets
	Acetazolamide		Intercranial hypertension (unlicensed indication)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next page
Last page

Building healthier lives